Select a country to find out more about GSK around the world.
All about our work fighting disease across the world
Read the stories behind our R&D operations
Stories about our many community projects around the world
Find out what our strategic priorities mean for our research, our people, our products and our partners
Find out things you didn't know about our everyday products
Find out all about our approach to caring for the planet
Find out about what GSK people have been up to, including our local and overseas community volunteers
Find out about GlaxoSmithKline's products.
Find out how science and innovation underpin our R&D in vaccines, medicines and consumer healthcare.
A comprehensive list of all our vaccines, medicines and consumer healthcare products.
Find out about the process behind the research and discovery of new medicines.
Find out how GlaxoSmithKline protects against disease.
Learn about how our clinical trials work, and also find out how to become a research volunteer yourself.
Find out how we research and develop new medicines that treat and prevent diseases of the developing world.
Information on when and how we use animals for research, how we ensure their welfare and how we limit their use.
Find locations where GlaxoSmithKline carries out its R&D operations.
Find out more about career opportunities in GlaxoSmithKline R&D.
Information on what we can offer you as an alliance partner, from business development and contract services, to academic collaborations and investment.
We know that our alliance partners face unique challenges and opportunities. We work to understand these issues and design an approach to match.
Find out how we work with academic institutions and who to contact if you are interested in working with us.
Find out how we work with partners in R&D and share our expertise, intellectual property and facilities to discover new medicines.
Find out how we ensure we have a steady supply of great ideas and innovative science from both inside and outside the company.
We provide contract manufacturing services in antibiotics, biopharmaceuticals and pharmaceuticals - find out more.
Find out all about our partnership with McLaren Group.
We strive to behave in an open and honest manner in all that we do – find out how we apply this to our business.
Learn about our commitment to the environment including our targets to cut emission and waste, and improve efficiency.
Find out how we are helping improve people’s health and well-being regardless of where they live or their ability to pay.
See how we work to support the development of our people around the world.
Our prescription medicines include treatments for a wide range of conditions such as infections, depression, skin conditions, asthma, heart and circulatory disease and cancer.
We produce more than 30 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, and more.
We bring dental health products, over-the-counter medicines and nutritional drinks to millions of people.
An overview of what GSK does worldwide including information on our three main business areas: Pharmaceuticals, Vaccines and Consumer Healthcare
Find out about our key achievements since we became GlaxoSmithKline in 2001
Find out who sits on GSK’s board of directors
Our Corporate Executive Team assists the CEO in managing the business – find out about its members
GSK was formed in 2000 when Glaxo Wellcome plc and SmithKline Beecham merged, but the combined histories of the two companies go back centuries. Find out more with our interactive timeline.
Information on the governance of GlaxoSmithKline, including details on the board committees, information for shareholders, and how we maintain our corporate ethics.
Find contact details for GlaxoSmithKline's main corporate offices in the UK and US.
Issued: Wednesday, 28th April 2010, London, U.K
Download GSK Q1 results 2010 as a PDF
For further details, videos and the analyst webcast, visit the Investors section of GSK.com.
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.
